US › Healthcare

Biora Therapeutics, Inc. (BIORQ)

US · Healthcare · Biotechnology

—

Latest quarter · ended 2024-09-30

Revenue

$32,000

Revenue YoY

+1500.0%

Net profit

$-18.4M

EPS

$-5.04

EPS estimate

$-3.85

Net margin

-57,506.2%

EPS came in at -5.04 against a street estimate of -3.85 — a miss of 30.9%.

Key statistics

Market cap

$994,994

P/E

0.6

Forward P/E

0.0

P/B

0.00

Book value

$-28.99

EPS (TTM)

$0.36

52-week high

$0.22

52-week low

$0.00

50-day MA

$0.22

200-day MA

$0.22

Beta

156.88

Shareholding

Insiders

6.57%

Institutions

77.23%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biora Therapeutics, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.